Eloxx Pharmaceuticals, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
120.00
|
|
Average Rating
|
5.00
|
|
# Strong Buys
|
1
|
|
# Buys
|
0
|
|
# Holds
|
0
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-4.40
|
-3.60
|
0.80
|
18.18%
|
|
2022-06-30
|
-4.13
|
-4.80
|
-0.67
|
-16.22%
|
|
2022-03-31
|
-3.70
|
-5.20
|
-1.50
|
-40.54%
|
|
2021-12-31
|
-4.80
|
-5.60
|
-0.80
|
-16.67%
|
|
2021-09-30
|
-5.40
|
-4.40
|
1.00
|
18.52%
|
|
2021-06-30
|
-5.50
|
-21.60
|
-16.10
|
-292.73%
|
|
2021-03-31
|
-6.40
|
-8.80
|
-2.40
|
-37.50%
|
|
2020-12-31
|
-8.60
|
-6.00
|
2.60
|
30.23%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-13.60
|
|
2021-12-31
|
-40.40
|
|
2020-12-31
|
-6.71
|
|
2019-12-31
|
-1.34
|
|
2018-12-31
|
-1.45
|
|
2017-12-31
|
-3.97
|
|
2016-12-31
|
-4.13
|
|
2015-12-31
|
-373.02
|
|
2014-12-31
|
-1629.31
|
|
2013-12-31
|
-1713.98
|
|
2012-12-31
|
-143.38
|
|
2011-12-31
|
-7677.90
|
|
2010-12-31
|
-7567.99
|
|
2009-12-31
|
-5903.44
|
|
2008-12-31
|
-27156.22
|
|
2006-12-31
|
-16643.65
|
|
2005-12-31
|
-15698.32
|
|
2004-12-31
|
-10958.48
|
|
2003-12-31
|
-18246.90
|
|
2002-12-31
|
-10921.85
|
|
2001-12-31
|
-15412.82
|
|
2000-12-31
|
-20793.99
|
|
1999-12-31
|
-20074.07
|